S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RGEN Repligen Corp

150.35

0.00 (0.00%)

Pre Market

Last Updated: 07:56:39

Delayed by 15 minutes

Repligen shares rise on strong first-quarter results, FY forecast raise

To read the full story on Seeking Alpha, click here.

Repligen (NASDAQ:RGEN)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Repligen Charts.

Repligen (NASDAQ:RGEN)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Repligen Charts.

Repligen Corp News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Repligen Corporation to Present at Upcoming June Investor Conferences
Wednesday 22 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Tuesday 21 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 17 May 2024 (3 weeks ago) • Edgar (US Regulatory)

More Repligen Corp News Articles

QED Connect (PK)

Iovance Biotherapeutics

ProText Mobility (PK)

Decentral Life (PK)

Enzolytics (PK)

GNCC Capital (CE)

AMC Entertainment

Ubiquitech Software (PK)

FuelCell Energy

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions